Skip to main content
. 2023 Feb 1;12(2):344. doi: 10.3390/antiox12020344

Table 1.

Stability, H2S release, and vasodilating activity of H2S donors.

Compd 1 Stability and H2S Release In
Human Serum
Vasodilating Activity
% Compd
(at 1, 4, 24 h) ± SE
or Half-Life
% H2S mol/mol
(at 1, 4, 24 h) Hours ± SE
EC50 (μM) ± SEM
[% Vasodilation]
+ Glib. 10 μM
EC50 (μM) ± SEM
[% Vasodilation]
1 88 ± 1 1 h 0.4 ± 0.1 1 h NA NA
35 ± 1 4 h 1.5 ± 0.1 4 h
8.0 ± 0.5 24 h 3.9 ± 0.9 24 h
2 t1/2 < 30 min 0.6 ± 0.3 1 h NA NA
1.8 ± 0.3 4 h
5 ± 1 24 h
3 80.0 ± 1.0 1 h 1.5 ± 0.2 1 h NA NA
62 ± 2 4 h 8.2 ± 0.3 4 h
44 ± 1 24 h 23 ± 2 24 h
4 t1/2 < 30 min 5.8 ± 0.2 1 h 64 ± 6 [44 ± 3] 2
10 ± 1 4 h
24.2 ± 0.9 24 h
5 64 ± 1 1 h 2.7 ± 0.2 1 h [16 ± 4] 3
39 ± 1 4 h 11 ± 2 4 h
16 ± 1 24 h 21 ± 1 24 h
6 t1/2 < 30 min 5.8 ± 0.2 1 h 47 ± 8 [34 ± 7] 2
10 ± 1 4 h
24.2 ± 0.8 24 h
7 19.8 ± 0.7 1 h 0.3 ± 0.2 1 h [12 ± 1] 3
0 4 h 1.4 ± 0.2 4 h
0 24 h 5 ± 1 24 h
8 t1/2 < 30 min 16 ± 1 1 h 40 ± 3 40 ± 4
25.8 ± 0.4 4 h
47 ± 1 24 h
9 94.2 ± 0.2 1 h 0.4 ± 0.1 1 h 78 ± 7 262 ± 62
90.0 ± 0.8 4 h 1.7 ± 0.6 4 h
83 ± 1 24 h 4.4 ± 0.9 24 h
10 t1/2 = 2.4 h 1.8 ± 0.3 1 h [29 ± 3] 4
7.5 ± 0.6 4 h
12.0 ± 0.9 24 h
11 96.3 ± 0.2 1 h 0.4 ± 0.4 1 h [42 ± 3] 2
90.0 ± 0.9 4 h 4 ± 1 4 h
53 ± 2 24 h 33 ± 4 24 h
12 t1/2 = 2.7 h 17 ± 8 1 h 20 ± 2 20 ± 3
63 ± 30 4 h
146 ± 34 24 h
13 99.2 ± 0.1 1 h 0 1 h [39 ± 8] 2
96.0 ± 0.8 4 h 0.7 ± 0.2 4 h
94.3 ± 2 24 h 2.4 ± 0.5 24 h
14 t1/2 = 30 min 0 1 h [37 ± 3] 4
0.5 ± 0.3 4 h
1.8 ± 0.6 24 h
15 99.2 ± 0.1 1 h 0.2 ± 0.4 1 h [17 ± 3] 3
95 ± 1 4 h 1.3 ± 0.2 4 h
94.8 ± 2 24 h 2.8 ± 0.5 24 h
16 t1/2 = 1.5 h 0.4 ± 0.2 1 h [25 ± 5] 2
1.7 ± 0.5 4 h
2.5 ± 0.9 24 h
17 91.6 ± 0.3 1 h 0.2 ± 0.2 1 h [27 ± 6] 3
85.0 ± 0.1 4 h 1.0 ± 0.3 4 h
64.7 ± 0.2 24 h 6 ± 1 24 h
18 t1/2 = 3.7 h 1.4 ± 0.4 1 h [33 ± 6] 4
11.0 ± 0.3 4 h
44 ± 2 24 h

1 Compound. 2 Percent vasodilation at the maximum concentration testable (100 μM). 3 Percent vasodilation at the maximum concentration testable (300 μM). 4 Percent vasodilation at the maximum concentration testable (10 μM).